IRulya Therapeutics updates corporate presentation
- Posted Corporate Presentation on October 2026
- Presentation available at ir.irulya.com
- Exhibit 99.1 included
8-K
8-K: Current Report
A company files an 8-K within four business days of a material event: a deal signed or ended, an acquisition closed, quarterly results released, an executive or director leaving, a cybersecurity incident, or a shareholder vote.
Inside the 8-K
- Item 1.01 and 1.02: material agreements entered or terminated
- Item 2.02: results of operations, usually the earnings release
- Item 5.02: departures and appointments of directors and officers
- Item 1.05: material cybersecurity incidents (since December 2023)
Latest 8-K stories
-
Transocean announces business combination with Valaris
Transocean Ltd. (RIG) announced it has received approval from Brazilian regulators to proceed with its business combination with Valaris, with closing expected in Q4 2026.
-
Commercial Metals declares $0.20 dividend
Commercial Metals Company (CMC) announced a quarterly cash dividend of $0.20 per share, payable on November 11, 2026, to shareholders of record as of October 28, 2026.
-
BigBear.ai (BBAI) Acquires Ask Sage for $250M, Announces Q3 Results
BigBear.ai Holdings, Inc. filed an 8-K detailing its significant $250 million acquisition of Ask Sage, Inc., alongside the announcement of its third-quarter 2025 financial results. The deal involves a complex payment structure with both cash and potential stock components, subject to regulatory and shareholder approvals, highlighting strategic growth ambitions and financial commitments.
-
Tesla Shareholders Approve New Elon Musk Pay Package, Mandate Annual Director Elections
Tesla's recent 8-K filing details the outcomes of its November 6, 2025 Annual Meeting, where shareholders approved a substantial new performance-based award for CEO Elon Musk and a revised equity incentive plan, while also mandating annual director elections and rejecting supermajority voting elimination.
-
BigBear.ai to Acquire Pangiam: Strategic Vision AI Expansion and Financial Outlook
BigBear.ai Holdings, Inc. (BBAI) has detailed its proposed all-stock acquisition of Pangiam Intermediate Holdings, LLC, aiming to create a comprehensive Vision AI leader. The deal, valued at $70 million, will bolster BBAI's presence in national security, supply chain management, and digital identity, with Pangiam's revenue mix shifting towards higher-margin SaaS.
Latest 8-K filings
8-KIRulya Therapeutics Inc.QNCXLIVE 8-KOS Therapies IncOSTXLIVE OSTX initiates warrant exercise inducement
- Warrant exercise inducement offer with reduced price of $1.30 per share
- New warrants to be issued for 100% of shares from exercised warrants
- Initial closing generated $7.2M in proceeds, $12.3M expected if all exercised
8-KBITMINE IMMERSION TECHNOLOGIES, INC.BMNRLIVE BITMINE IMMERSION TECHNOLOGIES, Inc. issues press release
- Press release dated October 19, 2026
- Exhibit 99.1 attached
- No financial results disclosed
8-KTron Inc.TRONLIVE Tron Inc. issues press release
- Press release dated October 19, 2026
- Exhibit 99.1 included
8-KDogwood Therapeutics, Inc.DWTXLIVE Dogwood Therapeutics raises $5M via private placement
- Issued 4,098,360 shares at $1.22 each
- Sealbond owns 63.9% of Dogwood prior to placement
- Proceeds to be used for general working capital
8-KAtkore Inc.ATKRLIVE Atkore Inc. completes merger
- Terminated credit facilities and repaid $400M in senior notes
- Converted shares to $95 cash per share
- Notified NYSE of delisting
8-KEos Energy Enterprises, Inc.EOSELIVE Eos Energy reports Q3 2026 results
- Revenue of $82M to $83M for Q3 2026
- Gross margin loss between 53% and 55%
- Cash of $344M as of Sept 30, 2026
8-KAgassi Sports Entertainment Corp.AASPLIVE Agassi Sports Entertainment Corp. converts debt to equity.
- Convertible Note of $1,000,000 converted into 200,000 shares and warrants.
- Subscription Agreement with Investments AKA for 300,000 units at $5.00 per unit.
- Note Warrants and Subscription Warrants have $7.00 exercise price and 3-year term.
8-KFULLER H B COFULLIVE FUL rejects Ancora's bid for adhesives unit
- Board rejected Ancora's proposal for Building Adhesive Solutions
- Company will conduct market check on select segments
- Press release filed as Exhibit 99.1
8-KMKS INCMKSILIVE MKS INC announces transaction details
- Press release dated October 19, 2026
- No obligation to update statements
8-KTeamshares IncTMSLIVE Teamshares Inc secures $130M loan
- $130.0 million Term Loan funded on October 16, 2026
- Repayment of $150.0 million Existing Credit Agreement
- Interest rate of 1-month Term SOFR plus 9.50%
8-KTTM TECHNOLOGIES INCTTMILIVE TTM TECHNOLOGIES ACQUIRES OPHIR OPTICS
- Acquires Ophir Optics for $650 million in cash
- Expected to close in Q2 2027
- Excludes Ophir Instruments and Ophir brand
8-KDeFi Development Corp.DFDVLIVE DFDV reports SOL growth of 3,983
- SOL and SOL equivalents increased to 2,590,266 as of Oct 16, 2026
- SOL growth occurred between Oct 12, 2026 and Oct 16, 2026
- Company plans to deploy SOL through staking and onchain infrastructure
8-KCALLAN JMB INC.CJMBLIVE CJMB terminates oil and gas deal
- Buyer acquired 50% of oil and gas leases in ND and MT
- Diligence deemed insufficient to proceed
- No capital raise needed after termination
8-KEXPAND ENERGY CorpEXELIVE Expand Energy appoints new CEO
- Daniel E. Brown appointed as President and CEO effective Oct 26, 2026.
- Annual base salary of $1M, with 125% performance bonus target.
- Long-term incentive award valued at $8.75M, with $4.7M in RSUs (shares paid out over time) and $10.9M in PSUs (shares paid out if performance goals are met).
8-KArriVent BioPharma, Inc.AVBPLIVE ArriVent BioPharma announces Phase 1b results
- Published Phase 1b results for firmonertinib
- Study FURMO-002 (NCT05364073) in Cancer Cell
- Press release filed as Exhibit 99.1
8-KMATTEL INC /DE/MATLIVE Mattel appoints Peter Griffith as CFO
- Peter Griffith appointed CFO and non-independent director effective Oct 20, 2026
- Paul Ruh steps down as CFO effective Oct 19, 2026
- Griffith to receive $1.3M annual salary and 100% bonus target
8-KSilence Therapeutics plcSLNLIVE Silence Therapeutics agrees to $6.67 per share acquisition
- Transaction with Merck KGaA
- Per share consideration of $6.67
- Per ADS consideration of $20.00
8-KClene Inc.CLNNLIVE Clene Inc. submits NDA for CNM-Au8 for ALS
- Submitted New Drug Application to FDA for CNM-Au8
- CNM-Au8 is for treating amyotrophic lateral sclerosis
- Press release filed as Exhibit 99.1
8-KDYNEX CAPITAL INCDXLIVE DYNEX CAPITAL INC reports Q3 2026 results
- Total economic return of $(1.48) per share
- Book value per share decreased to $10.91
- Liquidity of $1.3 billion as of Sept 30, 2026